Journal of Lipid Research Volume 55, 2014 455vitamin D signaling in numerous physiological and pharmacological processes ( 1 ). VDR is abundantly expressed in kidney, intestine, and bone, but is expressed at low levels in most other tissues ( 2 ). Defi ciency of VDR leads to hypocalcemia, hyperparathyroidism, rickets, osteomalacia, alopecia, uterine hypoplasia, and growth retardation, which might result from repression of calcium absorption due to downregulation of duodenal epithelial calcium channels ( 3-7 ). Recently, an intestine-specifi c VDR knockout mouse model ( Vdr ⌬ IEpC ) was generated that is defi cient of VDR in the small intestine and colon. These mice have abnormal body size, colon structure, and feces bile acid composition, and are more susceptible to experimentallyinduced infl ammatory bowel disease than WT mice ( 8 ). Feces metabolomics revealed decreased concentrations of taurine, taurocholic acid, taurodeoxycholic acid (TDCA), and cholic acid in Vdr ⌬ IEpC mice. In addition to the spontaneous accumulation of bile acids in VDR-defi cient mice, it was reported that VDR ligands inhibit bile acid synthesis and transcription of the gene encoding cholesterol 7 ␣ -hydroxylase (CYP7A1) ( 9, 10 ). In bile duct-ligated mice, 1 ␣ ,25-dihydroxy-vitamin D3 administration decreased liver bile acid content, increased the expression of bile acid transporters, and repressed pro-infl ammatory cytokine